Objectives-To identify causes for the continuing deficit of rubella immunity in women of childbearing age with a view to further reducing the risk of the congenital rubella syndrome.
Setting-Virus laboratory of the department of medical microbiology, Aberdeen, serving the health board areas of Grampian, Orkney, and Shetland.
Patients-239 women whose concentration of antibodies to rubella virus was either absent or below standard (15 000 IU/l) and whose general practitioner could be contacted to supply a history of infection, immunisation, pregnancy, and antibody testing.
Main outcome measures-Whether rubella vaccination was given and whether those vaccinated were tested for seroconversion.
Results-Only 122 (55%) of the women for whom information was available received the recommended vaccine; only 74 (61%) of these were tested for seroconversion. Oversight was the reason given for not vaccinating 64 (65%) of the women who remained at risk. Women who were pregnant when tested were significantly less likely to receive vaccine (odds ratio 3 36) than women who were not pregnant, and even if vaccinated were less likely to have a follow up antibody test (odds ratio 1.94).
Conclusion-Once women are identified as being unprotected against rubella they are often overlooked and not vaccinated. Prompting mechanisms aimed at general practitioners, such as the one recently set up in Grampian, should reduce the immunity gap and help to eradicate rubella in pregnancy.
Introduction
The aim of the selective immunisation policy for schoolgirls and women was to control and ultimately eliminate rubella in pregnancy.' 2 As a result, the susceptibility of antenatal women to rubella has declined to less than 2% Of the 257 unprotected women, 239 were available for study. A questionnaire was sent to the general practitioner of each woman to obtain demographic and rubella related data.
Results
Of the 239 questionnaires sent to general practitioners, 233 were returned, giving a response rate of 97% (91% of all unprotected women identified in 1987). Data from the laboratory reports were available for the six women whose questionnaire was not returned and for a further 12 women whose questionnaire was returned incomplete. who were screened routinely were subsequently found to be pregnant, and three who were screened at antenatal clinics were not pregnant. The rate of identification of unprotected women varied considerably between practices -of 98 practices within the laboratory catchment area, 28 did not receive any report of seronegativity and 24 received only one such report.
AGE AND PREGNANCY
From the questionnaire data 163 (68%) women were known to be pregnant when recruited to the study and could therefore not be vaccinated until after the pregnancy was completed. The pregnancy state of five women was not known. Table II gives the age distribution of the total study population, its non-pregnant and pregnant subgroups, and all women who delivered babies in the catchment area in 1987 (a reasonable comparison population for the pregnant subgroup). 71 showed satisfactory seroconversion, although one showed slow development of antibody over three months. Three women did not seroconvert to a satisfactory level: one woman who had been seronegative developed a low antibody level and two who had had low levels showed no response after vaccination. There was no record of vaccination or seroconversion for 98 (41%) of the 239 women. Of these women, 64 were said to have been "overlooked"; reasons given by the general practitioner for not vaccinating the remaining 34 women were non-attendance for vaccination (eight), pregnancy (seven), refusal (two), moving from the area (five), and the general practitioner not having been informed of the result (five) or thinking that vaccination was now unnecessary (seven-for whom presumably a further pregnancy was not contemplated). Pregnancy was found to be strongly associated with the action taken as a consequence of the women being found to be unprotected against rubella (table IV): 50% of pregnant women and 23% of non-pregnant women were not subsequently vaccinated (odds ratio 3-36, 95% confidence interval 1-76 to 6 38).
Even after vaccination those who were pregnant at the time of testing were less likely to have the follow up test to check for seroconversion, although the difference was not quite significant (43% (33/76) of pregnant BMJ VOLUME 303
9 NOVEMBER 1991 women and 28% (15/53) of non-pregnant women were untested: odds ratio 1-94%, 95% confidence interval 0-92 to 4 12).
Discussion
Most of the women in our study should have had at least one opportunity to be protected as a result of the rubella immunisation policy, either at school or postnatally, but had either not received vaccine or had not produced a satisfactory and persistent immune response. Rubella vaccine is known to induce antibody in almost 100% of susceptible subjects6 but occasionally there will be no detectable humoral response despite two or three booster doses. Therefore, even a complete record ofrubella vaccination at school or later is not a guarantee of lasting immunity. Moreover, rubella can occur in previously immune people, and recent findings have shown that when reinfection occurs in pregnancy the fetus is more likely to be affected than was previously supposed.7 This further emphasises the importance of continuing to monitor any possibility of rubella in pregnancy with or without symptoms and regardless of the woman's immune status.
We were not surprised that there was a high proportion of older women in our group as these women would not have been eligible for school vaccination. The slight preponderance of very young women was not expected but could have been due to slowing down of the campaign before its boost in 1983,8 or to a lower uptake of preventive services associated with young and single parent groups. Previous studies have shown racial differences both in rubella immunity and in the uptake rate of rubella vaccination in women,9 although our data do not allow us to make this comparison. Special effort may be necessary to achieve satisfactory rubella immunisation levels among women from ethnic minorities and deprived communities.
The action taken to protect the women in our study was disappointing. Most of the women who were not vaccinated after the 1987 screening were "overlooked." Many had been pregnant at the time of the screening test, and such women were significantly less likely to be vaccinated than those who had not been pregnant. Even if they were vaccinated they were less likely to be followed up. Failure to vaccinate promptly resulted in seven women becoming pregnant again before being immunised. Even women no longer considered likely to produce children should be vaccinated as they may pass on the infection to someone who is pregnant. A subsequent search of hospital records of the overlooked pregnant women showed that most of these had also missed being vaccinated in the hospital postnatal period, although in seven cases a record of hospital vaccination did exist. However efficient the system of postnatal vaccination in maternity hospitals, the general practitioner will still be involved in immunising patients who are discharged early and testing for seroconversion.
Similarly disappointing results were reported from Edinburgh,'" where susceptibility to rubella continued into second and subsequent pregnancies. Such oversight may be due to the necessary delay in vaccination until pregnancy is complete, or to the rarity and irrregularity with which any single general practitioner receives a report of a patient being negative for rubella virus antibody. It would therefore seem that schemes to ensure vaccination of seronegative women will usually be more effective if centrally based rather than limited to individual practices."
Our findings have led to the establishment in Grampian Health Board of a prompting mechanism initiated by the virus laboratory, which operates through the primary care register and the computerised immunisation system. This alerts the general practitioner when a recommended adult rubella vaccination has become overdue. If the appropriate action is then taken the immunity gap among pregnant women will be largely closed. This relatively simple mechanism may have application in other areas in the United Kingdom.
